PT Kalbe Farma Tbk. (PTKFF)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 191.7 Million | 82.23 Million | 201.29 Million | 303.57 Million | 185.46 Million | 197.7 Million |
| Net Income | 179.83 Million | 216.46 Million | 222.85 Million | 194.53 Million | 180.57 Million | 170.87 Million |
| Depreciation & Amortization | 47.54 Million | 46.85 Million | 47.16 Million | 45.34 Million | 36.72 Million | 32.18 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -35.67 Million | -181.08 Million | -68.72 Million | 63.68 Million | 41.61 Million | 59.02 Million |
| Investing Cash Flow | -80.5 Million | -90.84 Million | 3.85 Million | -76.53 Million | -132.7 Million | -94.08 Million |
| Investments in PPE | -76.63 Million | -55.68 Million | -70.06 Million | -79.58 Million | -142.83 Million | -98.46 Million |
| Acquisitions | 3.28 Million | -42.55 Million | 82.93 Million | 1.59 Million | 10.82 Million | 3.82 Million |
| Investment purchases | -11.77 Million | -8.12 Million | -17.5 Million | -8.11 Million | -693.84 Thousand | -452.01 Thousand |
| Sales/Maturities of investments | 4.62 Million | 15.81 Million | 8.48 Million | 9.56 Million | 24.35 | 1 Million |
| Other Investing Activities | 1.00 | -295.68 Thousand | -34.21 Million | 1.00 | -7.5 Billion | - |
| Financing Cash Flow | -155.22 Million | -151.65 Million | -133.41 Million | -72.54 Million | -60.28 Million | -79.88 Million |
| Debt repayment | -35.08 Million | -22.91 Million | -35.48 Million | -18.81 Million | -29.96 Million | -2.9 Million |
| Dividends payments | -114.25 Million | -104.4 Million | -91.87 Million | -86.74 Million | -87.79 Million | -81.49 Million |
| Common Stock Repurchased | - | -64.12 Million | - | -146.84 Thousand | - | - |
| Common Stock Issuance | - | -2.43 Million | - | -2.08 Million | - | - |
| Other Financing Activities | -3.76 Million | 42.22 Million | -6.05 Million | 35.23 Million | -2.45 Million | -1.3 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 252.78 Million | 435.13 Million | 370.67 Million | 219.01 Million | 219.28 Million | 205.24 Million |
| Cash at end of period | 210.1 Million | 252.78 Million | 435.13 Million | 370.67 Million | 219.01 Million | 219.28 Million |
| Capital Expenditure | -76.63 Million | -55.68 Million | -70.06 Million | -79.58 Million | -142.83 Million | -98.46 Million |
| Effect of forex changes on cash | -40.05 Billion | 237.77 Billion | -16.43 Billion | 51.26 Billion | -1.19 | - |
| Net cash flow / Change in cash | -42.67 Million | -182.35 Million | 64.46 Million | 151.65 Million | -269.82 Thousand | 14.03 Million |
| Free Cash Flow | 115.07 Million | 26.54 Million | 131.23 Million | 223.98 Million | 42.62 Million | 99.24 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 37.83 Million | 51.69 Million | 60.32 Million | 45.61 Million | 179.83 Million | 34.83 Million |
| Depreciation & Amortization | 13.22 Million | 11.37 Million | 12.09 Million | 11.2 Million | 47.54 Million | 12.22 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 27.24 Million | 31.26 Million | 28.78 Million | 37.59 Million | -35.67 Million | 13.75 Million |
| Investing Cash Flow | -14.49 Million | -32.53 Million | -21.14 Million | -27.22 Million | -80.5 Million | -16.89 Million |
| Investments in PPE | -17.5 Million | -21.95 Million | -22.2 Million | -26.96 Million | -76.63 Million | -18.56 Million |
| Acquisitions | 2.36 Million | -10.58 Million | 116.71 Thousand | 716.55 Thousand | 3.28 Million | 1.66 Million |
| Investment purchases | - | - | - | -974.94 Thousand | -11.77 Million | -58.50 |
| Sales/Maturities of investments | 1.01 Million | - | 945 Thousand | - | 4.62 Million | - |
| Other Investing Activities | - | 8723.43 | 2383.92 | -1.00 | 1.00 | 0.50 |
| Financing Cash Flow | -27.03 Million | -72.6 Million | 4.7 Million | -25.25 Million | -155.22 Million | -56.91 Million |
| Debt repayment | -16.93 Million | -19.17 Million | -5.23 Million | -24.58 Million | -35.08 Million | -55.51 Million |
| Dividends payments | - | -87.46 Million | - | - | -114.25 Million | - |
| Common Stock Repurchased | -9.59 Million | -1.36 Million | - | - | - | - |
| Common Stock Issuance | - | 188.39 Thousand | - | - | - | - |
| Other Financing Activities | -507.19 Thousand | -2.78 Million | -69.4 Thousand | 0.42 | -3.76 Million | -1.4 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 225.24 Million | 257.05 Million | 210.1 Million | 183.19 Million | 252.78 Million | 183.75 Million |
| Cash at end of period | 275.5 Million | 225.24 Million | 257.05 Million | 210.1 Million | 210.1 Million | 183.19 Million |
| Capital Expenditure | -17.5 Million | -21.95 Million | -22.2 Million | -26.96 Million | -76.63 Million | -18.56 Million |
| Effect of forex changes on cash | - | 162.2 Billion | -113.72 Billion | -129.84 Billion | -40.05 Billion | 174.33 Billion |
| Net cash flow / Change in cash | 50.26 Million | -31.81 Million | 46.94 Million | 26.91 Million | -42.67 Million | -562.24 Thousand |
| Free Cash Flow | 60.8 Million | 49.63 Million | 54.8 Million | 67.45 Million | 115.07 Million | 42.25 Million |
002826
JMJFIN
BDULF
SSRM
FRONTCORP
MRES